PLAT and ischemic stroke: A clinical trial revealed that although the administration of intravenous recombinant tissue plasminogen activator (t-PA) within 3 h of ischemic stroke onset can improve clinical outcomes at 3 months, it can also increase the incidence of intracerebral hemorrhage [5].